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Abstract 
Background. Ventricular repolarization dynamics (VRD) is an important predictor of 
outcome in diabetes. We examined the potential impact of coronary artery disease (CAD) on 
VRD in type 2 diabetic patients. 
Methods We recorded 5-min high-resolution resting electrocardiograms (ECG) in 38 diabetic 
patients undergoing elective coronary angiography, and in 38 age- and gender- matched 
apparently healthy subjects (Controls). Using leads I and 11, time-domain indices of VRD 
were calculated. Coronary angiography was regarded as positive if a 350% stenosis was 
found. 
Results Angiography was positive in 21 diabetic patients (55%). Patients with CAD had a 
significantly higher degree of VRD than Controls (SDNN(QT): 15.81k7.22 ms vs. 8.94+6.04 
ms; P <0.001, rMSSD(QT): 21.02k7.07 ms vs. 11.18k7.45 ms; P <0.001). VRD in diabetic 
patients with negatie angiograms did not differ from VRD in Controls (SDNN(QT): 
8.94+6.04 ms vs. 7.444~5.72 ms; P=0.67, rMSSD(QT): 11.18h7.45 ms vs. 10.2245.35 ms; 
P=O. 82). 
Conclusions CAD increases VRD in patients with type 2 diabetes. Therefore, changes in 
ventricular repolarization in diabetic patients may be due to silent CAD rather than to 
diabetes per se. 
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Background 
Cardiovascular disease represents the leading cause of death in patients with type 2 diabetes’. 
Stroke and cardiac death can be predicted in these patients by various measures of ventricular 
rep~larization~’~ . Mechanisms which may influence ventricular repolarization in type 2 
diabetes include autonomic nervous system abnormalities4, impaired insulin sensitivity, 
alterations of glucose homeostasis5, and coronary artery disease (CAD). Although several 
studies have demonstrated that CAD alters ventricular repolarization in non-diabetic 
subjects6,’, its impact on ventricular repolarization in diabetic patients remains unclear. This 
study was performed to better define the pathophysiologic background of repolarization 
abnormalities and the impact of CAD on ventricular repolarization dynamics (VRD) in 
patients with type 2 diabetes. 
Patient population and methods 
We performed a double-blind, case-control study in 38 diet-treated patients with type 2 
diabetes who underwent elective coronar)i angiography due to symptoms consistent with 
angina pectoris (Study group). The Control group included 38 age- and gender-matched, 
subjects without history of diabetes, with normal plasma glucose levels, and apparently 
healthy. Patients with hepatic or renal dysfunction, history of heart failure, or cerebrovascular 
disease were not included in the study. Likewise, patients treated with medications which 
may alter glucose homeostasis or ventricular repolarization, including thiazides, 
corticosteroids, phenothiazines, estrogens, sympathomimetics, type I and type I1 anti- 
arrhythmic drugs, were not studied. The study protocol was approved by the National Ethics 
Committee, and all patients granted their informed consent prior to entering the study. 
In all subjects, a 5-min high resolution 12-lead electrocardiogram (ECG) was 
recorded at the time of enrollment. In case of atrial, ventricular ectopy or inadequate signal 
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quality, the procedure was repeated. The ECG recordings were stored in a computer database 
and analyzed by an independent observer, who was blinded to the presence of CAD and 
diabetes mellitus. 
Cardiac Catheterization Technique 
In all patients from the Study group, cardiac catheterization was performed within 6 h after 
ECG recordings. Coronary angiography was performed using standard techniques. Stenotic 
lesions were graded subjectively by visual consensus of at least 2 experienced observers on 
an ordinal scale of 0%, 25%, 50%, 75%, 95%, or 100%. The catheterization result was 
regarded as positive if the coronary angiogram showed 250% stenosis in 31 major coronary 
artery. 
Analysis of Ventricular Repolarization Dynamics 
The analysis of VRD was performed with a computer-assisted beat-to-beat algorithm'. First, 
the template beat was constructed by averaging all beats based on superposition of the ECG 
signal according to the triggering point on the R wave. Then, the operator manually defined 
the analysis window ranging from end of QRS complex to the end of QT interval on the 
template signal. The T-wave of any beat of the 5-min recording was shifted to achieve the 
best fit with the template in the analysis window. For each beat, an error function was defined 
as the sum of the squared differences between the template and the incoming beat. QT 
interval duration of each beat was calculated with summation of template QT interval 
duration and error function parameter. Time-domain measures of VRD and heart rate 
variability were calculated according to the recommendations of the Task Force of the 
European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology'. 
Statistical Analysis 
Continuous variables were expressed as means * SD. The differences between the groups 
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were analyzed with 1 -factor analysis of variance. The comparisons of categorical variables 
were performed with a chi-square test. The parameters approaching statistical significance on 
univariate analyses were included in a multivariate model for prediction of increased VRD in 
diabetic subjects. P values c0.05 were considered significant. 
Results 
Patient Characteristics 
The baseline characteristics of the the Study and Control groups are presented in Table 1. The 
two groups did not differ with regards to age, gender, laboratory test results, heart rate, and 
prevalence of hypertension. 
Ventricular Repolarization Dynamics and Diabetes 
When compared to Controls, patients from the Study group had significantly higher values of 
VRD (SDNN(QT): 12.733~6.69 ms in the Study group vs. 7.4445.72 ms in Controls, P=O.Ol; 
rMSSD(QT): 16.62i7.24 ms in the Study group vs. 10.22*5.35 ms in Controls, P=O.Ol). 
However, the two groups did not differ with respect to heart rate variability parameters 
(SDNN(RR): 45.7*6.9 ms in the Study group vs. 46.0*5.2 ms in Controls, P=0.77, 
rMSSD(RR): 41.6*6.3 ms in the Study group vs. 40.2*7.5 ms in Controls, P=0.82). 
Ventricular Repolarization Dynamics and Coronary Artery Disease 
Coronary angiography was positive in 21 diabetic patients (55%). Patients with diabetes and 
CAD displayed a higher degree of VRD than diabetic patients with normal angiograms, and 
subjects from the Control group (Figure 1). No difference in VRD between diabetic patients 
with normal angiograms and the subjects from the Control group was found. 
Multivariate Analysis for Prediction of Increased Ventricular Repolarization Dynamics 
in Diabetes 
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Increased VRD, defined as either SNDD(QT)>12 ms, or rMSSD(QT)>16 ms, was present in 
27 diabetic patients (71%). The presence of CAD was the only independent predictor of 
increased VRD in our study (Table 2). 
Discussion 
The results of this study demonstrate that patients with type 2 diabetes have a higher degree 
of VRD than healthy subjects. Changes in VRD in diabetics were strongly related to the 
presence of CAD. We quantified VRD in diabetic patients using beat-to-beat QT interval 
variability measurements. This relatively new technique is highly reproducible, and is a 
reliable marker of ventricular electrical abnormalities, perhaps associated with a higher risk 
of life-threatening arrhythmiasg. The abnormal VRD present in over 70% of our diabetic 
patients is consistent with previous observations,' and suggests a high prevalence of 
ventricular repolarization abnormalities in type 2 diabetes. 
Although diabetics are at increased risk of sudden cardiac death", the mechanisms 
under!yir?g such death remain poorly defined. Cardiac autonomic neuropathy is an important 
disorder which can alter ventricular repolarization and lead to increased sudden cardiac death 
in this patient population". We found no differences in heart rate variability indices between 
diabetics and Controls, suggesting a relatively mild degree of autonomic nervous system 
impairment in our diabetic patients. Therefore, although a role played by the autonomic 
nervous system cannot be excluded, it seems unlikely to be responsible for the differences in 
VRD observed in our study. 
Changes in VRD in our diabetic patients were strongly associated with the presence 
of CAD. We have previously reported that non-diabetic patients with CAD have up to a 1.5- 
fold increase in VRD compared to healthy controls'. Furthermore, beat-to-beat QT interval 
variability has been associated with myocardial ischemia in coronary patients6. In large 
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population-based studies, the presence of altered ventricular repolarization, measured with 
JTc interval, was predictive of incident coronary heart diseaseI2. The combined results of 
these studies demonstrate that the presence of CAD can alter ventricular repolarization in 
various clinical settings. 
The impact of CAD on ventricular repolarization in diabetes is not well known. In a 
large population-based study, the prevalence of CAD was related to the QT interval in 
patients with newly diagnosed type 2 diabetesi3. In patients with type 1 diabetes, an increased 
QT dispersion was associated with ischemic heart disease and increased diastolic blood 
pressure, but not with neuropathyi4. Similarly, in type 2 diabetes, the presence of CAD was 
related both to prolonged QTc interval and increased QT interval di~persion'~. However, the 
QTc interval is significantly affected by neuroendocrine and metabolic factors, inflammation, 
and changes in sympathetic nervous activity.I6'l7 Therefore, QTc prolongation seems to be a 
marker of advanced disease rather than a simple reflection of ventricular repolarization 
instability. Although QT dispersion measurements have been proposed as an alternate risk 
marker in various clinical settings, their clinical use may be suspect as well as limited by poor 
reproducibility. 
VRD, measured by beat-to-beat QT interval variability, does not correlate with QTc 
interval duration and QT 
insights into the pathophysiology of abnormal ventricular repolarization in patients with type 
2 diabetes. Though the underlying mechanism of ventricular repolarization changes is not 
fully understood in these patients, it seems related to the presence of CAD. Considering the 
importance of ventricular repolarization changes in the pathogenesis of ventricular 
arrhythmias, we suggest that VRD measurements are a simple, non-invasive adjunct in the 
risk stratification of patients with type 2 diabetes. 
Therefore, the results of our study may offer new 
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Figure legend 
Figure 1: Ventricular repolarization dynamics in diabetic patients with, or without coronary 
artery disease (CAD), and in the control group (Controls) 
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Table 1: Baseline characteristics of subjects from the Study and Control groups 
Study Group Control Group P 
(N=38) (N=38) 
Age [years] 54 z!c 7 5 3 f 8  NS 
Male gender 22 (58) 22 (58) NS 
BMI [kg/m2] 29.9 z!c 3.6 30.9 f 5.2 NS 
Total cholesterol [mmol/l] 5.2 f 1.1 4.9 f 1.3 NS 
Potassium [mmol/l] 4.5 f 0.4 4.4 f 0.3 NS 
Calcium [mmoYl] 2.3 f 0.2 2.4 f 0.1 NS 
NS Magnesium [mmol/l] 2.3 f 0.3 2.2 f 0.3 NS 
Heart rate [bpm] 74 f 15 73 f 14 NS 
Systolic BP [mmHg] 131 f 2 1  129 f 24 NS 
Diastolic BP [mmHg] 8 6 f 1 1  8 2 f 8  NS 
Values are presented as meanASD or number (percent). BMI= body mass index; BP= blood 
pressure. 
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Table 2: Multivariate analysis of potential predictors of increased ventricular 
repolarization dynamics in patients with diabetes 
Multivariate Hazard ratio 
P-value (95% CI) 
Presence of CAD 0.008* 4.4 (1.4-13.7) 
Male gender 0.23 
Age >60 years 0.43 
Systolic BP>130 mmHg 0.45 - 
CAD = coronary artery disease; BP = blood pressure; *P c0.05. 
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